Fatty Acid Synthase (FASN) as a Therapeutic Target for Breast Cancer Metastasis

被引：0
|
作者：
Gonzalez-Guerrico, A. M. [1 ]
Lupu, R. [1 ]
机构：
[1] Mayo Clin, Mayo Canc Ctr, Rochester, MN USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：876S / 876S
页数：1
相关论文
共 50 条
  • [41] Lipocalin 2: a potential therapeutic target for breast cancer metastasis
    Hu, Chenxia
    Yang, Ke
    Li, Mengjie
    Huang, Weiping
    Zhang, Fengxue
    Wang, Hongqi
    ONCOTARGETS AND THERAPY, 2018, 11 : 8099 - 8106
  • [42] Neutrophil elastase as a therapeutic target to inhibit metastasis in breast cancer
    Lulla, Amriti Rajender
    Akli, Said
    Chrisikos, Taylor T.
    Pina, Marc A.
    Zhou, Yifan
    Li, Haiyan
    Watowich, Stephanie S.
    Keyomarsi, Khandan
    CANCER RESEARCH, 2020, 80 (04)
  • [43] Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology
    Menendez, Javier A.
    Cuyas, Elisabet
    Encinar, Jose Antonio
    Vander Steen, Travis
    Verdura, Sara
    Llop-Hernandez, Angela
    Lopez, Julia
    Serrano-Hervas, Eila
    Osuna, Silvia
    Martin-Castillo, Begona
    Lupu, Ruth
    MOLECULAR ONCOLOGY, 2024, 18 (03) : 479 - 516
  • [44] Fatty Acid Synthase (FASN) siRNA-Encapsulated-Her-2 Targeted Fab'-Immunoliposomes for Gene Silencing in Breast Cancer Cells
    Khan, Arif
    Aljarbou, Ahmed N.
    Aldebasi, Yousef H.
    Allemailem, Khaled S.
    Alsahli, Mohammed A.
    Khan, Shamshir
    Alruwetei, Abdulmohsen M.
    Khan, Masood A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 5575 - 5589
  • [45] Small-molecule Fatty Acid Synthase (FASN) inhibitors promote inhibition of tumor growth and induce apoptosis in breast cancer cells
    Lupu, Ruth
    Heuer, Timothy
    Kemble, George
    Kaufman, Scott
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S100 - S100
  • [46] Inhibition of mTOR and Fatty Acid Synthase (FASN) overcome acquired resistance to Trastuzumab, Lapatinib and both in HER2+breast cancer
    Puig, T.
    Blancafort, A.
    Giro, A.
    Viqueira, A.
    Vinas, G.
    Massaguer, A.
    Carrion-Salip, D.
    Bolos, M. V.
    Urruticoechea, A.
    Oliveras, G.
    CANCER RESEARCH, 2012, 72
  • [47] Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
    Lupu, Ruth
    Menendez, Javier A.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (06) : 483 - 494
  • [48] Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN/APP axis as novel therapeutic strategies
    Chen, Liang-Yun
    Wu, Dao-Sian
    Shen, Yao-An
    JOURNAL OF LIPID RESEARCH, 2024, 65 (11)
  • [49] Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells
    Vazquez-Martin, Alejando
    Ropero, Santiago
    Brunet, Joan
    Colomer, Ramon
    Menendez, Javier A.
    ONCOLOGY REPORTS, 2007, 18 (04) : 973 - 980
  • [50] Genetic and pharmacological inhibition of fatty acid synthase (FASN) attenuates prostate cancer driven by Pten loss
    Ribeiro, Caroline F.
    Bastos, Debora C.
    Pakula, Hubert
    Ahearn, Thomas
    Nascimento, Jessica
    Clohessy, John S.
    Mucci, Lorelei
    Zanata, Silvio M.
    Zadra, Giorgia
    Loda, Massimo
    CANCER RESEARCH, 2019, 79 (13)
12345